Contrast enhanced magnetic resonance imaging for uterine artery embolization efficiency assessment in women with leiomyoma uteri
https://doi.org/10.17650/1994-4098-2014-0-3-64-69
Abstract
Uterine artery embolization (UAE) is minimally invasive, less complicated and uterine-preserve procedure when compared to traditional surgical options. Magnetic resonance imaging (MRI) is the preferred modality in gynecologic pathology visualization. MRI is more accurate than transvaginal ultrasound in evaluating number, size and structure of the fibroids as well as their vascularization (by means of contrast enhancement) on pre-UAE uterus. On post-UAE contrast enhanced MRI, performed in 1, 6 and 12 month after the procedure, shrinkage of fibroids as well as the absence of their enhancement can be registered, showing the success or the manipulation. In case when leiomyoma is accompanied with adenomyosis, poor response of UAE can be noted by means of enhanced MRI revealing revascularization of fibroids. Thus, enhanced MRI is essential in UAE efficiency assessment, predicting treatment response and it’s complications.
About the Authors
Ye. A. PavlovskayaRussian Federation
Ye. A. Yukhno
Russian Federation
V. V. Ryazanov
Russian Federation
I. A. Trofimenko
Russian Federation
S. A. Sosin
Russian Federation
S. V. Serebryakova
Russian Federation
References
1. Zimmermann A., Bernuit D., Gerlinger C. et al. Prevalence, symptoms and management of uterine fibroids: an international internetbased survey of 21,746 women. BMC Womens Health 2012;12:6.
2. Kido A., Ascher S.M., Kishimoto K. et al. Comparison of uterine peristalsis before and after uterine artery embolization at 3-T MRI. AJR 2011;196(6):1431–5.
3. Hillard P.J.A. Benign diseases of the female reproductive tract: symptoms and signs. In: J.S. Berek, P.J.A. Hillard, E.Y. Adashi, eds. Novak’s gynecology. 13th ed. Philadelphia: Lippincott Williams & Wilkins, 2002. P. 351– 420.
4. Сидорова И.С., Унанян А.Л., Агеев М.Б. и др. Современное состояние вопроса о патогенезе, клинике, диагностике и лечении миомы матки у женщин репродуктивного возраста. Акуш гин, репрод 2012;6(4):22–8.
5. Вихляева Е.М. Руководство по диагностике и лечению больных лейомиомой матки. М.: МЕДпресс-информ, 2004. 400 с.
6. Руководство по лучевой диагностике в гинекологии. Под ред. Г.Е. Труфанова, В.О. Панова. СПб.: ЭЛБИ, 2008. 590 с.
7. Тихомиров А.М., Олейник Ч.Г., Лубнин Д.М. Тактика лечения больных миомой матки. Методическое пособие для врачей акушеров-гинекологов. М.: Медицинское информационное агентство, 2007. 176 с.
8. Bulman J.C., Ascher S.M., Spies J.B. Current concepts in uterine fibroid embolization. Radiographics 2012;32(6): 1735–50.
9. Walker W.J., Pelage J.P. Uterine artery embolization for symptomatic fibroids: clinical results in 400 women with imaging follow-up. BJOG 2002;109(11):1262–72.
10. Spies J.B., Ascher S.A., Roth A.R. et al. Uterine artery embolization for leiomyomata. Obstet Gynecol 2001;98(1):29–34.
11. Moss J., Cooper K., Khaund A. et al. Randomized comparison of uterine artery embolization (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG 2011; 118(8):936–44.
12. Tomislav S., Josip M., Liana C.S. et al. Uterine artery embolization as nonsurgical treatment of uterine myomas ISRN. Obstet Gynecol 2011;2011:489281.
13. Hubert J., Bergin D. Imaging the female pelvis: when should MRI be considered. Appl Radiol 2008;37(1):9–24.
14. Siddiqui N., Nikolaidis P., Hammond N., Miller F.H. Uterine artery embolization: preand postprocedual evaluation using magnetic resonance imaging. Abdom Imaging 2013; 38(5):1161–77.
15. Spielmann A.L., Keogh C., Forster B.B. et al. Comparison of MRI and sonography in the preliminary evaluation for fibroid embolization. AJR Am J Roentgenol 2006;187(6):1499–504.
16. Levens E.D., Wesley R., Premkumar A. et al. Magnetic resonance imaging and transvaginal ultrasound for determining fibroid burden: implications for clinical research. Am J Obstet Gynecol 2009;200(5): 537.e1–7.
17. Murase E., Siegelman E.S., Outwater E.K. et al. Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis and treatment. Radiographics 1999;19(5):1179–97.
18. Rein M.S., Barbieri R.L., Friedman A.J. Progesterone: а critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995:172(1 Pt 1):14–8.
19. Ueda H., Togashi K., Konishi I. et al. Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics 1999;19 Spec No: S131–45.
20. Weinreb J.C., Barkoff N.D., Megibow A., Demopoulos R. The value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminate. AJR Am J Roentgenol 1990;154(2):295–9.
21. Sung E.R., Byun J.Y., Jung S.E. et al. CT and MRI of uterine sarcomas and their mimickers. AJR Am J Roentgenol 2003;181(5):1369–74.
Review
For citations:
Pavlovskaya Ye.A., Yukhno Ye.A., Ryazanov V.V., Trofimenko I.A., Sosin S.A., Serebryakova S.V. Contrast enhanced magnetic resonance imaging for uterine artery embolization efficiency assessment in women with leiomyoma uteri. Tumors of female reproductive system. 2014;(3):64-69. (In Russ.) https://doi.org/10.17650/1994-4098-2014-0-3-64-69